Temporal trends in anticoagulation management for US active duty personnel with atrial fibrillation.
AVIATION MEDICINE
Adult cardiology
Cardiology
Pacing & electrophysiology
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
29 11 2022
29 11 2022
Historique:
entrez:
29
11
2022
pubmed:
30
11
2022
medline:
2
12
2022
Statut:
epublish
Résumé
ObjectivesThis study aims to investigate US active duty (AD) military members diagnosed with atrial fibrillation (AF) and the temporal trends of systemic anticoagulation (AC). Our secondary objective is to study the AC prescriptions in AD military members diagnosed with AF and associated military dispositions and deployment rates. A retrospective investigation of Tricare pharmacy AC prescriptions within the San Antonio Military Health System from January 2004 to July 2019 for AD individuals diagnosed with AF was performed. 386 AD personnel with non-valvular AF were analysed (mean age 35.0±9.4 years; mean body mass index, 28.3±4.3 kg/m The temporal trends of systemic AC prescriptions were the primary outcome measures. The association between AC prescriptions and military dispositions and deployments were secondary outcomes of interest. The association between AC management, future deployments and military disposition was analysed using χ CHA This is the first report describing AC utilisation in US AD military members with AF. Young AD personnel with low stroke and bleeding risks do not commonly receive AC prescriptions. DOAC prescription rates are increasing and predominate over warfarin for AC indications.
Identifiants
pubmed: 36446457
pii: bmjopen-2021-049394
doi: 10.1136/bmjopen-2021-049394
pmc: PMC9710344
doi:
Substances chimiques
Warfarin
5Q7ZVV76EI
Anticoagulants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e049394Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Am Heart Assoc. 2019 Sep 3;8(17):e012646
pubmed: 31441364
Heart Rhythm. 2011 Mar;8(3):e1-8
pubmed: 21324421
J R Army Med Corps. 2015 Sep;161(3):237-43
pubmed: 26246351
J Am Coll Cardiol. 2019 Jul 9;74(1):104-132
pubmed: 30703431
Hosp Pharm. 2018 Oct;53(5):286-291
pubmed: 30210144
J Atr Fibrillation. 2015 Dec 31;8(4):1309
pubmed: 27957228
Aviat Space Environ Med. 2013 Dec;84(12):1249-54
pubmed: 24459795
Circ Res. 2017 Apr 28;120(9):1501-1517
pubmed: 28450367
N Engl J Med. 2011 Sep 15;365(11):981-92
pubmed: 21870978
J Am Coll Cardiol. 2006 Aug 15;48(4):854-906
pubmed: 16904574
Circulation. 2014 Dec 2;130(23):e199-267
pubmed: 24682347
J Am Coll Cardiol. 2001 Oct;38(4):1231-66
pubmed: 11583910
J Am Coll Cardiol. 2017 May 23;69(20):2475-2484
pubmed: 28521884
N Engl J Med. 2011 Sep 8;365(10):883-91
pubmed: 21830957
Am J Epidemiol. 2018 Mar 1;187(3):417-426
pubmed: 28641376
Curr Treat Options Cardiovasc Med. 2019 Dec 10;21(12):85
pubmed: 31820122
Am J Med. 2015 Dec;128(12):1300-5.e2
pubmed: 26144101
N Engl J Med. 2009 Sep 17;361(12):1139-51
pubmed: 19717844
Lancet. 2014 Mar 15;383(9921):955-62
pubmed: 24315724
JAMA. 2019 Apr 2;321(13):1261-1274
pubmed: 30874766
Clin Epidemiol. 2013 Dec 09;5:475-81
pubmed: 24353441